2 for 1 Deal... Idiopathic Thrombocytopenic Purpura and Abciximab

Idiopathic thrombocytopenic purpura and the drug abciximab both target platelet membrane glycoprotein IIb-IIIa. ITP is an immune destruction of platelets. Besides being impossible to pronounce, abciximab is used in patients undergoing percutaneous coronary intervention, and is an antiplatelet agent.

1 comment:

  1. quick question, doesnt idiopathic mean we dont know whats causing the dz? How can this be idiopathic, if we know its due to immune destruction?

    ReplyDelete